Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.02 Million USD | -39.9% |
| 2022 | 11.69 Million USD | -73.06% |
| 2021 | 43.39 Million USD | -15.86% |
| 2020 | 51.56 Million USD | 13.27% |
| 2019 | 45.52 Million USD | 74.22% |
| 2018 | 26.13 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 9.46 Million USD | -19.02% |
| 2023 FY | 7.02 Million USD | -39.9% |
| 2023 Q2 | 8.88 Million USD | -6.16% |
| 2023 Q3 | 8.08 Million USD | -8.95% |
| 2023 Q4 | 7.02 Million USD | -13.13% |
| 2022 FY | 11.69 Million USD | -73.06% |
| 2022 Q4 | 11.69 Million USD | -1.88% |
| 2022 Q3 | 11.91 Million USD | -42.92% |
| 2022 Q2 | 20.87 Million USD | -53.38% |
| 2022 Q1 | 44.76 Million USD | 3.18% |
| 2021 Q2 | 70.95 Million USD | -4.43% |
| 2021 Q1 | 74.24 Million USD | 43.97% |
| 2021 FY | 43.39 Million USD | -15.86% |
| 2021 Q4 | 43.39 Million USD | -18.84% |
| 2021 Q3 | 53.46 Million USD | -24.64% |
| 2020 Q4 | 51.56 Million USD | -4.47% |
| 2020 FY | 51.56 Million USD | 13.27% |
| 2020 Q3 | 53.98 Million USD | 9.35% |
| 2020 Q2 | 49.36 Million USD | -21.82% |
| 2020 Q1 | 63.14 Million USD | 38.7% |
| 2019 Q4 | 45.52 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 45.52 Million USD | 74.22% |
| 2018 FY | 26.13 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bright Green Corporation | 6.43 Million USD | -9.132% |
| BioQuest Corp. | 632.89 Thousand USD | -1010.135% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | 95.929% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | -86.261% |
| GSRX Industries Inc. | - USD | -Infinity% |
| High Sierra Technologies, Inc. | 611.78 Thousand USD | -1048.443% |
| Instadose Pharma Corp. | - USD | -Infinity% |